Grantham, Mayo, Van Otterloo & Co (GMO)’s Henry Schein HSIC Stock Holding History
Bought
Maintained
Sold
Other funds holding HSIC
GIM
Grantham, Mayo, Van Otterloo & Co (GMO)'s HSIC Position: Q1 2024 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Henry Schein (HSIC) in Q1 2024, closing a stake of 5,003 shares — an estimated $379K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HSIC in Q2 2013 and held it in 22 quarters. The position peaked at $36.2M in Q1 2015. 543 funds tracked by Wall St. Rank hold HSIC as of Q1 2024.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Henry Schein position as of Q1 2024 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,003 Henry Schein shares in Q1 2024, an estimated $379K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Henry Schein in Q2 2013 and held it in 22 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Henry Schein position peaked at $36.2M in Q1 2015.
- 543 funds tracked by Wall St. Rank held Henry Schein as of Q1 2024.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.